Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mills

Showing results (781-790 of 888) with videos related to

Pageof 89
Sort By:
Nature Reviews. Urology|January 16, 2026
Circulating tumour cells as a window into lethality in prostate cancerSophia M Abusamra, Thineskrishna Anbarasan, Daniele T Cotton, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2010
Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonistsChangyou Zhou, Cheng Tang, Eric Chang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 AntagonistAlexander Pasternak, Zhe Feng, Reynalda de Jesus, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chainsDong-Ming Shen, Min Shu, Sander G Mills, et al.
Oncotarget|April 19, 2017
Lipid degradation promotes prostate cancer cell survivalHarri M Itkonen, Michael Brown, Alfonso Urbanucci, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2021
Changes in Circulating Kisspeptin Levels During Each Trimester in Women With Antenatal ComplicationsAli Abbara, Maya Al-Memar, Maria Phylactou, et al.
Fertility and Sterility|May 31, 2021
Performance of plasma kisspeptin as a biomarker for miscarriage improves with gestational age during the first trimesterAli Abbara, Maya Al-Memar, Maria Phylactou, et al.
Nature Communications|July 16, 2024
Metabolic imaging across scales reveals distinct prostate cancer phenotypesNikita Sushentsev, Gregory Hamm, Lucy Flint, et al.
Cell Reports|July 3, 2026
Yeast β-glucan supplementation supports immunometabolic anti-tumor responses and reverses obesity-induced dysfunction via trained hematopoiesisAnna E Ledwith, Hannah Prendeville, Cian Jh Horneck Johnston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
CCR5 blockade modulates inflammation and alloimmunity in primatesCarsten Schröder, Richard N Pierson, Bao-Ngoc H Nguyen, et al.
Pageof 89

Showing results (781-790 of 888) with videos related to

Sort By:
Pageof 89
Nature Reviews. Urology|January 16, 2026
Circulating tumour cells as a window into lethality in prostate cancerSophia M Abusamra, Thineskrishna Anbarasan, Daniele T Cotton, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2010
Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonistsChangyou Zhou, Cheng Tang, Eric Chang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 AntagonistAlexander Pasternak, Zhe Feng, Reynalda de Jesus, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chainsDong-Ming Shen, Min Shu, Sander G Mills, et al.
Oncotarget|April 19, 2017
Lipid degradation promotes prostate cancer cell survivalHarri M Itkonen, Michael Brown, Alfonso Urbanucci, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2021
Changes in Circulating Kisspeptin Levels During Each Trimester in Women With Antenatal ComplicationsAli Abbara, Maya Al-Memar, Maria Phylactou, et al.
Fertility and Sterility|May 31, 2021
Performance of plasma kisspeptin as a biomarker for miscarriage improves with gestational age during the first trimesterAli Abbara, Maya Al-Memar, Maria Phylactou, et al.
Nature Communications|July 16, 2024
Metabolic imaging across scales reveals distinct prostate cancer phenotypesNikita Sushentsev, Gregory Hamm, Lucy Flint, et al.
Cell Reports|July 3, 2026
Yeast β-glucan supplementation supports immunometabolic anti-tumor responses and reverses obesity-induced dysfunction via trained hematopoiesisAnna E Ledwith, Hannah Prendeville, Cian Jh Horneck Johnston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
CCR5 blockade modulates inflammation and alloimmunity in primatesCarsten Schröder, Richard N Pierson, Bao-Ngoc H Nguyen, et al.
Pageof 89